• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    12 Health Care Stocks Moving In Wednesday's Intraday Session

    4/10/24 12:31:24 PM ET
    $ACOR
    $ADIL
    $BPTS
    $BSGM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACOR alert in real time by email

    Gainers

    • Adial Pharmaceuticals (NASDAQ:ADIL) shares rose 61.6% to $1.83 during Wednesday's regular session. The company's market cap stands at $7.4 million.
    • Jaguar Health (NASDAQ:JAGX) shares rose 32.22% to $0.12. The market value of their outstanding shares is at $32.8 million.
    • Orgenesis (NASDAQ:ORGS) stock rose 27.83% to $0.62. The market value of their outstanding shares is at $21.1 million.
    • BioSig Technologies (NASDAQ:BSGM) shares moved upwards by 15.43% to $1.87. The company's market cap stands at $17.4 million.
    • Etao International Co (NASDAQ:ETAO) shares rose 14.65% to $4.38. The company's market cap stands at $22.4 million.
    • Telomir Pharmaceuticals (NASDAQ:TELO) shares rose 12.84% to $7.73. The market value of their outstanding shares is at $228.8 million.

    Losers

    • Acorda Therapeutics (NASDAQ:ACOR) stock decreased by 20.4% to $0.81 during Wednesday's regular session. The company's market cap stands at $1.0 million.
    • Kineta (NASDAQ:KA) shares declined by 18.14% to $0.35. The market value of their outstanding shares is at $3.8 million.
    • DocGo (NASDAQ:DCGO) shares declined by 17.67% to $3.17. The market value of their outstanding shares is at $330.2 million.
    • Biophytis (NASDAQ:BPTS) shares decreased by 15.67% to $0.35. The market value of their outstanding shares is at $4.0 million.
    • Yield10 Bioscience (NASDAQ:YTEN) stock declined by 14.9% to $0.32. The company's market cap stands at $4.9 million.
    • Eyenovia (NASDAQ:EYEN) shares declined by 12.05% to $0.54. The company's market cap stands at $25.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACOR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACOR
    $ADIL
    $BPTS
    $BSGM

    CompanyDatePrice TargetRatingAnalyst
    DocGo Inc.
    $DCGO
    5/9/2025Buy → Neutral
    BTIG Research
    DocGo Inc.
    $DCGO
    2/28/2025$5.00 → $2.85Buy → Hold
    Deutsche Bank
    Telomir Pharmaceuticals Inc.
    $TELO
    2/21/2025$15.00Buy
    Rodman & Renshaw
    Eyenovia Inc.
    $EYEN
    11/18/2024$12.00 → $2.00Buy → Neutral
    H.C. Wainwright
    Adial Pharmaceuticals Inc
    $ADIL
    11/14/2024$8.00Buy
    Rodman & Renshaw
    Yield10 Bioscience Inc.
    $YTEN
    2/8/2024Buy → Hold
    Lake Street
    DocGo Inc.
    $DCGO
    8/18/2023$15.00Buy
    BTIG Research
    DocGo Inc.
    $DCGO
    4/21/2023$11.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $ACOR
    $ADIL
    $BPTS
    $BSGM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Adial Pharmaceuticals Commends Congress on Introduction of Bipartisan Legislation Expanding Access to Emerging AUD Therapies for Veterans

    GLEN ALLEN, Va., March 24, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of treatments for addiction and related disorders, today commended members of the U.S. Congress for introducing H.R. 7091, the Expanding Veterans' Access to Emerging Treatments Act, bipartisan legislation aimed at expanding research and development of emerging therapies for conditions affecting U.S. veterans, specifically including Alcohol Use Disorder (AUD). Alcohol Use Disorder remains a significant issue within the veteran population, with nearly 40% of veterans experiencing AUD at some point in t

    3/24/26 9:07:00 AM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ethisphere Names DocGo as One of the 2026 World's Most Ethical Companies®

    20th annual recognition honors organizations committed to business integrity through robust ethics, compliance, and governance programs DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled medical transportation and mobile health services, announced today that it has been recognized as one of the 2026 World's Most Ethical Companies® by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. This is DocGo's first time receiving this honor, and the Company is one of only four honorees in the healthcare providers and services category. In 2026, 138 honorees were recognized, spanning 17 countries and 40 indu

    3/18/26 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Announces Fourth Quarter and Full Year 2025 Results

    Company Raises 2026 Revenue and Adjusted EBITDA Guidance due to Customer Expansions, Improved EMS Hiring Rates and Efficiency Initiatives Company Has Initiated a Formal Process to Explore Strategic Alternatives to Maximize Shareholder Value Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Total revenue for the fourth quarter of 2025 was $74.9 million, compared t

    3/16/26 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $ACOR
    $ADIL
    $BPTS
    $BSGM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for MYDCOMBI issued to EYENOVIA INC.

    Submission status for EYENOVIA INC.'s drug MYDCOMBI (ORIG-1) with active ingredient TROPICAMIDE AND PHENYLEPHRINE HYDROCHLORIDE has changed to 'Approval' on 05/05/2023. Application Category: NDA, Application Number: 215352, Application Classification: Type 5 - New Formulation or New Manufacturer

    5/8/23 1:05:04 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $ADIL
    $BPTS
    $BSGM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Giustra Frank bought $734,725 worth of shares (178,205 units at $4.12) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    9/15/25 8:19:20 PM ET
    $BSGM
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Burdiek Michael J bought $13,300 worth of shares (10,000 units at $1.33), increasing direct ownership by 2% to 641,560 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    5/23/25 4:25:30 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Director Burdiek Michael J bought $21,450 worth of shares (15,000 units at $1.43), increasing direct ownership by 2% to 631,560 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    5/15/25 5:05:47 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $ACOR
    $ADIL
    $BPTS
    $BSGM
    SEC Filings

    View All

    Telomir Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Telomir Pharmaceuticals, Inc. (0001971532) (Filer)

    3/27/26 5:00:09 PM ET
    $TELO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by DocGo Inc.

    SCHEDULE 13G/A - DocGo Inc. (0001822359) (Subject)

    3/26/26 6:03:49 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    SEC Form 10-K filed by Orgenesis Inc.

    10-K - Orgenesis Inc. (0001460602) (Filer)

    3/26/26 1:19:17 PM ET
    $ORGS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $ADIL
    $BPTS
    $BSGM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $ACOR
    $ADIL
    $BPTS
    $BSGM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Director Micek John was granted 7,377 shares, increasing direct ownership by 13,919% to 7,430 units (SEC Form 4)

    4 - Jaguar Health, Inc. (0001585608) (Issuer)

    3/12/26 3:03:56 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer King Steven R. was granted 11,740 shares, increasing direct ownership by 8,097% to 11,885 units (SEC Form 4)

    4 - Jaguar Health, Inc. (0001585608) (Issuer)

    1/21/26 4:30:46 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer Conte Lisa A was granted 28,592 shares, increasing direct ownership by 4,293% to 29,258 units (SEC Form 4)

    4 - Jaguar Health, Inc. (0001585608) (Issuer)

    1/21/26 4:30:40 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    DocGo downgraded by BTIG Research

    BTIG Research downgraded DocGo from Buy to Neutral

    5/9/25 8:41:42 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded DocGo from Buy to Hold and set a new price target of $2.85 from $5.00 previously

    2/28/25 8:51:46 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Rodman & Renshaw initiated coverage on Telomir Pharmaceuticals with a new price target

    Rodman & Renshaw initiated coverage of Telomir Pharmaceuticals with a rating of Buy and set a new price target of $15.00

    2/21/25 8:16:21 AM ET
    $TELO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $ADIL
    $BPTS
    $BSGM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Orgenesis Inc.

    SC 13G/A - Orgenesis Inc. (0001460602) (Subject)

    12/4/24 6:51:18 PM ET
    $ORGS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Orgenesis Inc.

    SC 13G/A - Orgenesis Inc. (0001460602) (Subject)

    12/4/24 6:50:26 PM ET
    $ORGS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Eyenovia Inc.

    SC 13D/A - EYENOVIA, INC. (0001682639) (Subject)

    12/4/24 4:12:20 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $ADIL
    $BPTS
    $BSGM
    Financials

    Live finance-specific insights

    View All

    DocGo Announces Fourth Quarter and Full Year 2025 Results

    Company Raises 2026 Revenue and Adjusted EBITDA Guidance due to Customer Expansions, Improved EMS Hiring Rates and Efficiency Initiatives Company Has Initiated a Formal Process to Explore Strategic Alternatives to Maximize Shareholder Value Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Total revenue for the fourth quarter of 2025 was $74.9 million, compared t

    3/16/26 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo to Announce Fourth Quarter and Full Year 2025 Results on Monday, March 16, 2026

    Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled medical transportation and mobile health services, announced today that the Company will release its financial results for the fourth quarter and full year ended December 31, 2025, after the markets close on Monday, March 16, 2025. Management will also host a conference call to discuss these results and its outlook for 2026 at 5:00 p.m. ET on that day. Conference call and webcast details: Monday, March 16, 2026 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) Conference ID: 74028 To access the Call m

    3/2/26 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Announces Third Quarter 2025 Results

    Company Achieves Record Volumes Across All Major Business Lines Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Total revenue for the third quarter of 2025 was $70.8 million, compared to $138.7 million in the third quarter of 2024. This decline was entirely due to the wind-down of migrant-related programs, which generated $8.4 million in the third quarter of 2025 and $80.7 million in

    11/10/25 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $ACOR
    $ADIL
    $BPTS
    $BSGM
    Leadership Updates

    Live Leadership Updates

    View All

    BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor

    BioSig Technologies, Inc. ("BioSig" or the "Company"), which recently merged with Streamex Exchange Corporation ("Streamex") (NASDAQ:BSGM), is pleased to announce the appointment of Russell Starr as Strategic Advisor to Streamex. Mr. Starr brings decades of experience in capital markets, business development, and transformative deal-making across, defi, traditional finance and emerging sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250711280588/en/ A former executive on Bay Street and respected entrepreneur and financier, Mr. Starr has built a reputation for navigating high-stakes financial transactions and guiding comp

    7/11/25 9:00:00 AM ET
    $BSGM
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

    LAGUNA HILLS, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN) ("Eyenovia" or the "Company"), a pioneer in ophthalmic technologies and the first publicly-listed U.S. company to build a strategic treasury of HYPE, the native token of the Hyperliquid protocol, today announced several key developments in support of its digital asset capital strategy. Avenue Capital Group, now the Company's largest common stockholder, has agreed to amend Eyenovia's senior secured debt to further support the Company as it builds its HYPE treasury and reserve of the HYPE token. Pursuant to the terms of the amendment, the maturity date of the debt has been extended from November 1, 2025 to

    6/18/25 8:32:42 AM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors

    Los Angeles, CA & Vancouver, BC, June 09, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ:BSGM) ("BioSig"), which acquired Streamex Exchange Corporation as its wholly owned subsidiary ("Streamex") in May 2025, is pleased to announce the appointment of Trevor Bacon and Kellan Grenier, co-founders of Parcl, as Strategic Advisors. Together, they bring deep expertise at the intersection of decentralized finance, synthetic asset creation, and real-world asset tokenization. Parcl is a leading blockchain-native platform that enables users to gain exposure to real estate markets through synthetic, perpetual trading. Built on Solana, the platform offers users the ability to speculate on

    6/9/25 10:30:00 AM ET
    $BSGM
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care